• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?

作者信息

Kielstein J T, Frölich J C, Haller H, Fliser D

机构信息

Department of Nephrology, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.

出版信息

Nephrol Dial Transplant. 2001 Sep;16(9):1742-5. doi: 10.1093/ndt/16.9.1742.

DOI:10.1093/ndt/16.9.1742
PMID:11522849
Abstract
摘要

相似文献

1
ADMA (asymmetric dimethylarginine): an atherosclerotic disease mediating agent in patients with renal disease?
Nephrol Dial Transplant. 2001 Sep;16(9):1742-5. doi: 10.1093/ndt/16.9.1742.
2
Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?不对称二甲基精氨酸：肾脏疾病发病机制中的新因素？
Curr Opin Nephrol Hypertens. 2006 May;15(3):314-20. doi: 10.1097/01.mnh.0000222701.22583.e8.
3
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.不对称二甲基精氨酸（ADMA）是心血管疾病和慢性肾脏病肾损伤发生发展过程中一种新出现的危险因素。
Clin Exp Nephrol. 2007 Jun;11(2):115-121. doi: 10.1007/s10157-007-0471-x. Epub 2007 Jun 28.
4
Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism.非对称二甲基精氨酸（ADMA）在血管、肾脏及肝脏疾病中的作用以及L-精氨酸对其代谢的调节作用
Mol Genet Metab. 2007 Aug;91(4):309-17; discussion 308. doi: 10.1016/j.ymgme.2007.04.017. Epub 2007 Jun 7.
5
Asymmetric dimethylarginine (ADMA) modulates endothelial function--therapeutic implications.
Vasc Med. 2003;8(3):149-51. doi: 10.1191/1358863x03vm501ed.
6
Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule.不对称二甲基精氨酸（ADMA）：一氧化氮合酶的内源性抑制剂及一种新型心血管风险分子。
Med Sci Monit. 2009 Apr;15(4):RA91-101.
7
Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule.不对称二甲基精氨酸（ADMA）：从“尿毒症毒素”到全身性心血管风险分子的悄然转变。
Eur J Clin Invest. 2005 Feb;35(2):71-9. doi: 10.1111/j.1365-2362.2005.01457.x.
8
Arginine, arginine analogs and nitric oxide production in chronic kidney disease.慢性肾脏病中的精氨酸、精氨酸类似物与一氧化氮生成
Nat Clin Pract Nephrol. 2006 Apr;2(4):209-20. doi: 10.1038/ncpneph0143.
9
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases.不对称二甲基精氨酸、内皮型一氧化氮合酶途径紊乱与心血管疾病
Semin Thromb Hemost. 2000;26(5):539-45. doi: 10.1055/s-2000-13210.
10
Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance.不对称二甲基精氨酸（ADMA）及其他内源性一氧化氮合酶（NOS）抑制剂是血管胰岛素抵抗的重要原因。
Horm Metab Res. 2008 Sep;40(9):655-9. doi: 10.1055/s-0028-1083814. Epub 2008 Sep 15.

引用本文的文献

1
Heparin-Mediated Extracorporeal Low-Density Lipoprotein Precipitation Apheresis for Treating Peripheral Arterial Disease in Patients with Chronic Kidney Disease.肝素介导的体外低密度脂蛋白沉淀单采术治疗慢性肾脏病患者的外周动脉疾病
J Clin Med. 2024 Feb 16;13(4):1121. doi: 10.3390/jcm13041121.
2
The Diverse Efficacy of Food-Derived Proanthocyanidins for Middle-Aged and Elderly Women.食物来源原花青素对中年和老年女性的多种功效。
Nutrients. 2020 Dec 15;12(12):3833. doi: 10.3390/nu12123833.
3
Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study.
非布司他对合并血管内皮功能障碍的血液透析患者氧化应激的影响：一项随机、安慰剂对照、双盲研究。
Int Urol Nephrol. 2019 Sep;51(9):1649-1657. doi: 10.1007/s11255-019-02243-w. Epub 2019 Aug 1.
4
Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients.血液透析患者血清不对称和对称二甲基精氨酸与发病率及死亡率
Am J Kidney Dis. 2017 Jul;70(1):48-58. doi: 10.1053/j.ajkd.2016.10.033. Epub 2017 Jan 12.
5
Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.肾功能决定了载脂蛋白E基因多态性对高血压患者不对称二甲基精氨酸的调节作用。
Lipids Health Dis. 2016 Jan 20;15:14. doi: 10.1186/s12944-016-0182-y.
6
Homocystein as a risk factor for developing complications in chronic renal failure.同型半胱氨酸作为慢性肾衰竭发生并发症的一个风险因素。
Mater Sociomed. 2015 Apr;27(2):95-8. doi: 10.5455/msm.2015.27.95-98. Epub 2015 Apr 5.
7
A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations.他汀类药物对血浆不对称二甲基精氨酸浓度影响的系统评价与荟萃分析。
Sci Rep. 2015 May 13;5:9902. doi: 10.1038/srep09902.
8
Associations of proanthocyanidin intake with renal function and clinical outcomes in elderly women.原花青素摄入量与老年女性肾功能和临床结局的关系。
PLoS One. 2013 Aug 5;8(8):e71166. doi: 10.1371/journal.pone.0071166. Print 2013.
9
Nitric oxide manipulation: a therapeutic target for peripheral arterial disease?一氧化氮调控：外周动脉疾病的治疗靶点？
Cardiol Res Pract. 2012;2012:656247. doi: 10.1155/2012/656247. Epub 2012 Mar 20.
10
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?睾酮和磷酸二酯酶 5 抑制剂：预防内科学和性医学中内皮损伤的新策略？
Ther Adv Urol. 2009 Oct;1(4):179-97. doi: 10.1177/1756287209344992.